MODERNA, INC. Toevoegen aan een lijst
|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 108 USD | +1,69% |
|
+6,47% | +8,57% |
| 24/04 | Sectorupdate: Gezondheidszorgaandelen dalen aan het eind van de middag | MT |
| 24/04 | Moderna gaat samenwerken met OpenAI om nieuwe generatie medicijnen te lanceren | MT |
Totale waarde
| Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Marktkapitalisatie 1 | 6.518 | 41.340 | 102.976 | 69.006 | 37.919 | 41.340 | - | - |
| Bedrijfswaarde 1 | 5.548 | 36.842 | 92.848 | 59.104 | 29.315 | 36.607 | 37.960 | 38.019 |
| K/w-verhouding | -12,6 x | -53,3 x | 8,98 x | 8,93 x | -8,07 x | -14,9 x | -20,3 x | -60,1 x |
| Dividendrendement | - | - | - | - | - | - | - | - |
| Marktkapitalisatie/omzet | 108 x | 51,5 x | 5,58 x | 3,58 x | 5,54 x | 9,82 x | 8,56 x | 6,44 x |
| Bedrijfswaarde/omzet | 92,1 x | 45,9 x | 5,03 x | 3,07 x | 4,28 x | 8,7 x | 7,86 x | 5,93 x |
| Bedrijfswaarde/EBITDA | -10,8 x | -50,3 x | 6,86 x | 6,05 x | -8,1 x | -13 x | -17,9 x | -50,9 x |
| Bedrijfswaarde/FCF | -11,3 x | 18,8 x | 6,96 x | 12,9 x | -7,66 x | -13,5 x | -20,1 x | -62,7 x |
| FCF Yield | -8,84% | 5,32% | 14,4% | 7,75% | -13% | -7,41% | -4,98% | -1,6% |
| Price to Book | 6,14 x | 16,3 x | 7,24 x | 3,7 x | 2,74 x | 3,53 x | 4,69 x | 5,39 x |
| Aantal aandelen (in duizenden) | 333.250 | 395.710 | 405.450 | 384.180 | 381.284 | 382.880 | - | - |
| Referentieprijs 2 | 19,56 | 104,5 | 254,0 | 179,6 | 99,45 | 108,0 | 108,0 | 108,0 |
| Datum van publicatie | 26/02/20 | 25/02/21 | 24/02/22 | 23/02/23 | 22/02/24 | - | - | - |
1USD in Miljoen2USD
Geschatte gegevens
Evolutie van de resultatenrekening (Jaargegevens)
| Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 60,21 | 803,4 | 18.471 | 19.263 | 6.848 | 4.210 | 4.829 | 6.415 |
| EBITDA 1 | -514,7 | -731,9 | 13.528 | 9.768 | -3.618 | -2.824 | -2.117 | -747,3 |
| Bedrijfsresultaat (EBIT) 1 | -545,7 | -763,1 | 13.296 | 9.420 | -4.239 | -3.070 | -2.303 | -958,5 |
| Operationele Marge | -906,38% | -94,99% | 71,98% | 48,9% | -61,9% | -72,93% | -47,7% | -14,94% |
| Resultaat voor belastingen (EBT) 1 | -514,7 | -744,5 | 13.285 | 9.575 | -3.942 | -2.772 | -1.942 | -353 |
| Nettowinst (verlies) 1 | -514 | -747,1 | 12.202 | 8.362 | -4.714 | -2.807 | -2.080 | -737,1 |
| Nettomarge | -853,73% | -92,99% | 66,06% | 43,41% | -68,84% | -66,68% | -43,08% | -11,49% |
| WPA 2 | -1,550 | -1,960 | 28,29 | 20,12 | -12,33 | -7,248 | -5,310 | -1,797 |
| Free Cash Flow 1 | -490,5 | 1.960 | 13.336 | 4.581 | -3.825 | -2.711 | -1.891 | -606,8 |
| FCF-marge | -814,7% | 243,91% | 72,2% | 23,78% | -55,86% | -64,41% | -39,16% | -9,46% |
| Kasstroomconversie (ebitda) | - | - | 98,58% | 46,9% | - | - | - | - |
| Kasstroomconversie (nettowinst) | - | - | 109,29% | 54,78% | - | - | - | - |
| Dividend per aandeel 2 | - | - | - | - | - | - | - | - |
| Datum van publicatie | 26/02/20 | 25/02/21 | 24/02/22 | 23/02/23 | 22/02/24 | - | - | - |
1USD in Miljoen2USD
Geschatte gegevens
Evolutie van de resultatenrekening (Kwartaalgegevens)
| Fiscaal tijdperk: december | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 4.969 | 7.211 | 6.066 | 4.749 | 3.364 | 5.084 | 1.862 | 344 | 1.831 | 2.811 | 125,3 | 72,22 | 1.584 | 2.428 | 632,6 |
| EBITDA | - | 5.488 | - | - | - | - | - | - | - | 208 | - | - | - | - | - |
| Bedrijfsresultaat (EBIT) 1 | 3.558 | 5.410 | 4.227 | 2.447 | 1.166 | 1.580 | -366 | -1.867 | -2.012 | 6 | -1.412 | -1.393 | -374,7 | 169,4 | -976,6 |
| Operationele Marge | 71,6% | 75,02% | 69,68% | 51,53% | 34,66% | 31,08% | -19,66% | -542,73% | -109,89% | 0,21% | -1.126,94% | -1.929,48% | -23,65% | 6,98% | -154,39% |
| Resultaat voor belastingen (EBT) 1 | 3.552 | 5.410 | 4.229 | 2.474 | 1.217 | 1.655 | -305 | -1.749 | -1.958 | 70 | -1.338 | -1.340 | -314,6 | 212,6 | -818,7 |
| Nettowinst (verlies) 1 | 3.333 | 4.868 | 3.657 | 2.197 | 1.043 | 1.465 | 79 | -1.380 | -3.630 | 217 | -1.387 | -1.371 | -362,6 | 275,3 | -818,7 |
| Nettomarge | 67,08% | 67,51% | 60,29% | 46,26% | 31% | 28,82% | 4,24% | -401,16% | -198,25% | 7,72% | -1.106,73% | -1.898,82% | -22,89% | 11,34% | -129,42% |
| WPA 2 | 7,700 | 11,29 | 8,580 | 5,240 | 2,530 | 3,610 | 0,1900 | -3,620 | -9,530 | 0,5500 | -3,572 | -3,529 | -0,8781 | 0,5977 | -2,562 |
| Dividend per aandeel 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Datum van publicatie | 4/11/21 | 24/02/22 | 4/05/22 | 3/08/22 | 3/11/22 | 23/02/23 | 4/05/23 | 3/08/23 | 2/11/23 | 22/02/24 | - | - | - | - | - |
1USD in Miljoen2USD
Geschatte gegevens
Balans
| Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Nettoschuldpositie 1 | - | - | - | - | - | - | - | - |
| Nettokaspositie 1 | 971 | 4.498 | 10.128 | 9.902 | 8.604 | 4.733 | 3.380 | 3.320 |
| Hefboom (schuld/ebitda) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | -491 | 1.960 | 13.336 | 4.581 | -3.825 | -2.711 | -1.891 | -607 |
| ROE (netto-inkomsten/eigen vermogen) | -38% | -40% | 146% | 50,3% | -28,6% | -22,7% | -20,3% | -9,08% |
| ROA (netto-inkomsten/totale activa) | -28,9% | -16,7% | 76,2% | 33,1% | -21,3% | -16,5% | -14,3% | -12,5% |
| Totale activa 1 | 1.776 | 4.463 | 16.003 | 25.264 | 22.142 | 17.010 | 14.558 | 5.920 |
| Nettoactief per aandeel 2 | 3,190 | 6,420 | 35,10 | 48,50 | 36,30 | 30,60 | 23,00 | 20,00 |
| Cashflow per aandeel 2 | - | 5,320 | 31,60 | 12,00 | -8,160 | -6,090 | -3,110 | 2,080 |
| Capex 1 | 31,6 | 67,4 | 284 | 400 | 707 | 902 | 461 | 399 |
| Capex/omzet | 52,41% | 8,4% | 1,54% | 2,08% | 10,32% | 21,42% | 9,56% | 6,22% |
| Datum van publicatie | 26/02/20 | 25/02/21 | 24/02/22 | 23/02/23 | 22/02/24 | - | - | - |
1USD in Miljoen2USD
Geschatte gegevens
WPA & Dividend
Historische koers/winstverhouding
Evolutie van de historische prestaties
Historische marktkapitalisatie/EBITDA
Trading rating
Beleggingsrating
ESG Refinitiv
B-
Verkoop
Koop
Gemiddeld advies
Accumuleren
Aantal analisten
26
Laatste slotkoers
108
USD
Gemiddelde koersdoel
134,3
USD
Spread / Gemiddelde doel
+24,39%
Herzieningen van WPA
| Vaira. 1 jan. | Kapi. | |
|---|---|---|
| +8,57% | 41,34 mld. | |
| +1,51% | 42,75 mld. | |
| +49,22% | 41,61 mld. | |
| -12,36% | 26,59 mld. | |
| +8,92% | 25,49 mld. | |
| -25,13% | 18,12 mld. | |
| +29,17% | 12,24 mld. | |
| -3,12% | 11,76 mld. | |
| +6,35% | 11 mld. | |
| -16,98% | 10,07 mld. |
- Beurs
- Aandelen
- Koers MRNA
- Financiën Moderna, Inc.
